Healthcare Patent Filing Outsourcing Market Size | Companies
The healthcare patent filing outsourcing market size was exhibited at USD 1.65 billion in 2024 and is projected to hit around USD 2.54 billion by 2034, growing at a CAGR of 4.4% during the forecast period 2024 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 1.72 Billion |
| Market Size by 2034 | USD 2.54 Billion |
| Growth Rate From 2024 to 2034 | CAGR of 4.4% |
| Base Year | 2024 |
| Forecast Period | 2024-2034 |
| Segments Covered | Domain, Service, Origin, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America, Europe, Asia Pacific, Latin America, MEA |
| Key Companies Profiled | Clarivate; ipMetrix CRJ IPR Services LLP; Patent Outsourcing Limited; Synoptic IP PVT LTD; Dennemeyer Group; POWELL GILBERT; Bristows LLP; HOYNG ROKH MONEGEIER; CARPMAELS & RANSFORD LLP |
Pharmaceutical and biotechnology companies invest significant funds in research & development for innovative medicines and medical devices that deliver positive results for patients. The growing innovation in medical devices and robust pharmaceutical and biopharmaceutical product pipelines propels the market growth.
The number of patent applications by these companies has increased in recent years. According to the information by the European Patent Office, it received a total of 15985 patent applications in the medical technology sector in 2024. To reduce costs and improve operational efficiency, many of these companies chose to outsource their patent application processes to third-party service providers, which has increased the demand for medical patent application outsourcing services.
Many pharmaceutical and biotechnology companies such as AbbVie, AGC Biologics, Amgen, Novartis, and Thermo Fisher Scientific are investing substantially in new manufacturing facilities worldwide and expanding their operations abroad to enter new markets and expand their customer base. As a result, there is an increased demand for medical patent application outsourcing services, as these companies need expert guidance to navigate the complex patent laws and regulations of different countries.
The market is witnessing significant growth due to increasing investment in healthcare research and development, leading to increased healthcare applications requiring patent protection. Medtronic inaugurated its newly expanded state-of-the-art MEIC in Hyderabad, India to expand its global R&D footprint and invest in the local innovation ecosystem.
Major trends shaping the market include increasing adoption of artificial intelligence and machine learning tools in patent research and analysis, growing demand for expertise in emerging healthcare sectors, emphasis on patent quality and strategic portfolio management, and expansion of patent services, commercialization, technology, and transmission support. The acceleration of healthcare innovations, the need for cost-effective patent services, and the globalization of healthcare companies indicate the growth factors.
The pharmaceutical segment dominated the market and accounted for the largest revenue share of 50.4% in 2024 due to the increasing investments by the pharmaceutical industry in research and development to develop new drugs, treatments, and innovative health solutions. Pfizer, one of the pharmaceutical companies, invested USD 11.4 billion in research and development in 2022, with a significant portion for developing novel therapies and enhancing existing treatments across various therapeutic areas, including oncology, immunology, and rare diseases.
The medtech segment market is highly competitive and is projected to witness a steady CAGR in the forecast period. The medtech segment is further sub-segmented into assistive care devices, consumables and disposables, diagnosis and imaging devices, drug delivery devices, surgical devices, and wearable medical devices. The wearable medical devices segment is expected to expand rapidly over the forecast period due to the mounting demand for such devices in telehealth services and improving health consciousness among people.
The filing and prosecution segment dominated the healthcare patent filing outsourcing market and accounted for the largest revenue share of 51.9% in 2024 attributed to the company complexity associated with filing and prosecution coupled with cost-efficiency by outsourcing such tasks. In-house filing and prosecution can also consume more than the required time for internal resources. Therefore, the time savings in filing and processing activities offered by medical outsourcing companies will boost the segment growth during the forecast period.
The pre-filing segment is likely to witness a significant CAGR over the forecast period. Pre-filing is a crucial step in patent filing, as it requires due diligence before filing a patent. If the filing steps are done unprofessionally and without being competent in the patent processes, the procedures can be reapplied, which is mostly a time-consuming process for business organizations. Therefore, the demand for competency and professional service highlights the need for pre-filing services.
The resident segment dominated the market and accounted for the largest revenue share of 64.0% in 2024. Approximately 70% of the overall patents registered in the WIPO repository are resident patents. The resident segment is a crucial component of the market. This segment refers to the outsourcing of patent filing and prosecution activities to service providers located within the client’s location, region, and country. Many healthcare companies prefer to work with resident outsourcing partners due to their familiarity with local patent laws, regulations, and language requirements.
The non-resident segment is projected to expand with a steady CAGR over the forecast period. The popularity of this segment has grown as a result of the healthcare industry's expanding global reach and the demand for extensive patent safeguarding in multiple markets. Also, with the help of local patent outsourcing firms and the know-how of local regulations is beneficial for applicants to get a patent in another country. Such factors contribute to the growth of non-resident segment over the forecast period.
North America accounted for a significant revenue share in 2024. Healthcare companies possess cutting-edge technologies, research facilities, and financial resources, which empower them to conduct extensive research and development endeavors. Companies frequently opt to delegate their patent filing procedures to specialized service providers in order to streamline operations, cut down on expenses, and capitalize on the expertise in patent prosecution.
U.S. Healthcare Patent Filing Outsourcing Market Trends
The healthcare patent filing outsourcing market in the U.S. dominated North America in terms of revenue share in 2024. Due to the strong presence of pharmaceutical, biotechnology, and medical device industries in the country, the need for outsourcing patent filing and prosecution services is steadily increasing.
Asia Pacific Healthcare Patent Filing Outsourcing Market Trends
Asia Pacific dominated the global market and accounted for the largest revenue share of 66.1% in 2024. The region is home to several emerging economies with rapidly growing healthcare industries. The number of patents filed in the medical device technology sector by countries across the globe has witnessed exponential growth for certain nations. China, India, and Japan are the top three countries to account for the maximum number of patents filed in the recent years.
Europe Healthcare Patent Filing Outsourcing Market Trends
The Europe healthcare patent filing outsourcing market is expected to witness a steady CAGR driven by the well-established pharmaceutical and biotech industries. The Europe healthcare patent filing outsourcing market is growing significantly due to the region’s strong focus on innovating new patent technologies. The demand for outsourcing services is increasing due to the presence of pharmaceutical manufacturers. This is expected to drive market growth in the forecast period.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the healthcare patent filing outsourcing market
Domain
Service
Origin
Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers